Attached files
file | filename |
---|---|
S-1/A - FORM S-1/A - Cascadian Therapeutics, Inc. | v58606a2sv1za.htm |
EX-23.2 - EX-23.2 - Cascadian Therapeutics, Inc. | v58606a2exv23w2.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Post-Effective Amendment No. 2 to Registration
Statement No. 333-169746 on Form S-1 of our report dated May 5, 2010, relating to the 2008 and 2009
consolidated financial statements of Oncothyreon Inc. and subsidiaries, appearing in the Annual
Report on Form 10-K of Oncothyreon Inc. for the year ended December 31, 2010, and to the reference
to us under the heading Experts in the Prospectus, which is part of such Registration Statement.
/s/ Deloitte & Touche LLP
Seattle, Washington
March 14, 2011
March 14, 2011